"MSK's Breakthroughs Revolutionize Acute Cancer Therapies in Latest Research"
Researchers at Memorial Sloan Kettering Cancer Center have made significant advances in cancer treatment, including the development of a new CAR T cell therapy that targets specific antigens in acute myeloid leukemia (AML) while potentially sparing healthy cells. This, along with insights into genetic elements and stem cell regulation, represents a promising step forward in the fight against cancer.